UNSPSC 51373408: Ammonium/antimony/chlorpheniramine/codeine/potassium guaiacolsulfonate

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE301. This VA Drug Class (RE301) classifies this compound as belonging to the group OPIOID-CONTAINING ANTITUSSIVES/EXPECTORANTS.

UNSPSC 51373408 Ammonium/antimony/chlorpheniramine/codeine/potassium guaiacolsulfonate is a Commodity code under which state and local governments procure pharmaceutical products and related healthcare supplies, specifically parenteral nutrition solutions, intravenous medications, and controlled substances for correctional and community health settings. The Washington State Department of Corrections issued RFQ RFQQK13020 in September 2026 soliciting parenteral products, services, and equipment including TPN and PPN solutions, IV solutions, and other parenteral products for eight correctional facilities across Washington, with response due October 7, 2026. State and local issuing bodies under this code include correctional departments and county health departments. The Washington solicitation encourages participation from small businesses (25%), minority-owned businesses (10%), women-owned businesses (6%), and veteran-owned businesses (5%), with aspirational 5% Small and Diverse Business Goals and Subcontractor Inclusion Plan requirements.

The code sees recent activity concentrated in Washington and Florida. The Washington State Department of Corrections dominates the identified recent opportunities, with the September 2026 RFQ anticipating selection of up to three contractors per region and an initial contract term running November 26, 2026 through June 30, 2030. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026 for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building, response due July 26, 2023. The Washington solicitation requires parenteral nutrition bags delivered within 24 hours of order, other parenteral products within 8 hours, and firms must demonstrate documented experience preparing and delivering IV solutions and adjusting nutrition preparations. Contractors must maintain Commercial General Liability ($1 million per occurrence / $2 million aggregate), Professional Liability ($2 million per occurrence / aggregate), Business Automobile Liability ($1 million per occurrence / $2 million aggregate), and Cyber Liability ($2 million per occurrence / aggregate).